NAWAF ALANAZI et al. INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 29, n. 01, p. 476–492, 2022. DOI: 10.53555/68zhqm37. Disponível em: https://jptcp.com/index.php/jptcp/article/view/7959. Acesso em: 12 sep. 2025.